Ads
related to: laboratory tests for tuberous sclerosis- The Confience Platform
Everything you need to accurately
gather, track, and analyze data.
- Request a Demo
See the best-in-class LIMS in
action. Request a live demo today.
- Resource Center
Explore free LIMS resources and
stories of Confience customers.
- About Us
Dedicated to building trusted
products for a thriving planet.
- The Confience Platform
Search results
Results From The WOW.Com Content Network
Tuberous sclerosis complex affects multiple organ systems so a multidisciplinary team of medical professionals is required. [citation needed] In suspected or newly diagnosed TSC, the following tests and procedures are recommended by 2012 International Tuberous Sclerosis Complex Consensus Conference. [25]
These multifocal lesions are observed in tuberous sclerosis, [6] [7] and can be associated with lymphangioleiomyomatosis [8] and perivascular epithelioid cell tumour (PEComa or clear cell "sugar tumor")). [9] It can be diagnosed through lung biopsy using thoracoscopy. [10]
Defects in this gene can cause tuberous sclerosis, due to a functional impairment of the TSC complex. [citation needed] Defects in TSC1 may also be a cause of focal cortical dysplasia. [citation needed] TSC1 may be involved in protecting brain neurons in the CA3 region of the hippocampus from the effects of stroke. [7]
Tuberous sclerosis proteins 1 and 2, also known as TSC1 (hamartin) and TSC2 (tuberin), form a protein-complex. The encoding two genes are TSC1 and TSC2 . The complex is known as a tumor suppressor.
Pharmacological inhibition of ERK1/2 restores GSK3β activity and protein synthesis levels in a model of tuberous sclerosis. [8]The defective degradation of glycogen by the autophagy-lysosome pathway is, at least in part, independent of impaired regulation of mTORC1 and is restored by the combined use of PKB/Akt and mTORC1 pharmacological inhibitors.
The Rothberg Institute For Childhood Diseases is a non-profit organization dedicated to finding a cure for rare childhood diseases such as Tuberous Sclerosis Complex (TSC). The organization was founded by Jonathan Rothberg and his wife in 2002 after their son was born with TSC. [1] [2] [3] [4]
Although the prevalence of tuberous sclerosis at 1 in 6,000 births is much greater than that of LAM, most pulmonary clinics see more cases of sporadic than tuberous sclerosis–LAM: probably due to a combination of low levels of screening for LAM in tuberous sclerosis and in many, the absence of symptoms. [citation needed]
Subependymal giant cell astrocytoma (SEGA, SGCA, or SGCT) is a low-grade astrocytic brain tumor (astrocytoma) that arises within the ventricles of the brain. [1] It is most commonly associated with tuberous sclerosis complex (TSC).
Ad
related to: laboratory tests for tuberous sclerosis